which was confirmed by the experiment in vivo of HepG2-bearing nude mice, supporting that the MetFab-DOX could have therapeutic prospective for treating HCC
In this examine, we present that a novel ADC (MetFab-DOX) consisting of doxorubicin conjugated to a human anti-c-Achieved Fab c857066-90-1…